Welcome to our dedicated page for Manhattan Associates SEC filings (Ticker: MANH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Manhattan Associates Inc. filings document operating results, governance and executive compensation for a Georgia-incorporated supply chain and omnichannel commerce software company. Form 8-K reports furnish quarterly earnings releases and discuss GAAP results alongside adjusted operating income, adjusted net income and adjusted diluted earnings per share.
The company’s regulatory record also includes current reports on officer succession and related compensation arrangements, including restricted stock units and executive employment terms. Its definitive proxy materials cover board and shareholder matters, executive pay tables, equity awards and pay-versus-performance disclosures.
Manhattan Associates, Inc. has launched a cost-reduction plan that will cut its global workforce by approximately 6%. The company expects to record about $7 million to $9 million of mostly cash expenses in the second quarter of 2026, primarily for severance and other one-time termination benefits, and aims to substantially complete the plan by the end of that quarter.
Manhattan plans to exclude these restructuring charges from future presentations of its non-GAAP financial measures. The company also reaffirmed its previously issued 2026 financial guidance, stating that the outlook under its “2026 Guidance” remains in place as referenced in an earlier press release.
Manhattan Associates, Inc. reported that its Board approved, and shareholders subsequently adopted, a First Amendment to the company’s 2020 Equity Incentive Plan. The Board adopted the amendment on March 20, 2026, and shareholders approved it at the 2026 Annual Meeting on May 14, 2026.
The amendment increases the number of shares of common stock issuable under the plan by an additional 3,000,000 shares and extends the plan’s term to March 20, 2036. The company refers investors to its Definitive Proxy Statement and the full plan and amendment texts, which are filed as exhibits, for complete terms.
SHEER DANIELLE reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Danielle Sheer received a grant of 1,940 shares of Common Stock on May 14, 2026. The award was issued at no cash cost to her and is structured as restricted stock units under the company’s stock incentive plan. After this grant, she holds 3,270 shares directly. The units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, tying the award to continued board service over that period.
Manhattan Associates director Kimberly A. Kuryea received an equity grant as part of her compensation. On May 14, 2026, she acquired 1,940 shares of common stock at no cost through a restricted stock unit award under the company’s stock incentive plan. The units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this grant, she directly holds 8,027 shares of Manhattan Associates common stock.
Eger Edmond reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Edmond Eger reported an equity award of company stock. He received 1,940 shares of common stock as a restricted stock unit grant under the company’s stock incentive plan, reported at a transaction price of $0.00 per share.
The grant vests fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Following this award, Eger’s direct ownership stands at 8,453 shares of common stock.
Hollembaek Linda T. reported acquisition or exercise transactions in this Form 4 filing.
Manhattan Associates Inc. director Linda T. Hollembaek received a grant of 1,940 shares of common stock as restricted stock units under the company’s stock incentive plan. The award was at no cash cost per share and lifts her direct holdings to 13,847 shares, vesting fully on the earlier of the next annual shareholders’ meeting or the first anniversary of the grant date.
NOONAN THOMAS E reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Thomas E. Noonan received a grant of 1,940 shares of common stock in the form of restricted stock units under the company’s stock incentive plan. The award vests in full on the earlier of the next annual shareholder meeting or the first anniversary of the grant date.
Following this equity award, Noonan directly holds 103,800 shares of Manhattan Associates common stock, reflecting routine, compensation-related stock-based pay rather than an open-market purchase.
MORAN CHARLES E reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Charles E. Moran reported an equity award and updated holdings. He received a grant of 1,940 shares of Common Stock at $0.0000 per share as a compensation-related award, lifting his direct holdings to 3,270 shares. The award is a restricted stock unit grant under the company’s stock incentive plan, vesting fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date. Moran also reported 20,808 shares held indirectly by a trust, reflecting his indirect ownership position.
Capel Eddie reported acquisition or exercise transactions in this Form 4 filing.
MANHATTAN ASSOCIATES INC director Eddie Capel received 1,940 shares of Common Stock as a restricted stock unit grant. The award was made at no cash cost per share as part of the company’s stock incentive plan. Following this grant, Capel directly holds 156,329 shares of the company’s common stock.
The restricted stock units vest fully on the earlier of the next annual meeting of shareholders or the first anniversary of the grant date, aligning director compensation with shareholder interests over that period.
Manhattan Associates, Inc. reported the results of its 2026 Annual Meeting of Shareholders. As of the March 18, 2026 record date, 59,162,073 common shares were entitled to vote, and 55,764,873 shares were present in person or by proxy, representing about 94% participation.
Shareholders elected Class I directors Eddie Capel, Charles E. Moran, and Linda T. Hollembaek to terms expiring in 2029. They also approved, on a non-binding basis, the compensation of the named executive officers, ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, and approved the First Amendment to the company’s 2020 Equity Incentive Plan.